Ignite Creation Date:
2024-05-06 @ 12:09 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01509131
Status:
COMPLETED
Last Update Posted:
2012-01-12
First Post:
2012-01-04
Brief Title:
Evaluation of a Mixed Bowel Prep 2L PEG Bisacodyl Versus PEG With Ascorbate
Sponsor:
Promefarm Srl
Organization:
Promefarm Srl
Study Overview
Official Title:
Low Volume Bowel Preparation for Colonoscopy a Comparison Between PEG-CS Plus Bisacodyl Versus PEG-ASC
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is hypothesized that PEG 2L with citrate and simeticone plus bisacodyl will have similar bowel cleansing efficacy versus PEG 2L with ascorbate Safety tolerability acceptance and compliance of the two reduced volume PEG-based bowel preparation will be also compared
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None